AI Eyewear Risks And Store Saturation Will Limit Long Term Margin Expansion

Catalysts

About Warby Parker

Warby Parker is an eyewear and vision care company that sells glasses, contacts, and eye exams through a vertically integrated omnichannel model.

What are the underlying business or industry changes driving this perspective?

• The push into AI glasses with Google and Samsung introduces high execution and adoption risk, and if consumer uptake of intelligent eyewear stalls or pricing misses the mark, the company could see limited incremental revenue while absorbing ongoing R&D and lab investments that pressure net margins.
• Heavy reliance on store growth and suburban densification in a category already served by many physical optometry and retail chains could lead to slower productivity gains from new locations over time, which would weigh on revenue per store and delay earnings leverage.
• The increased use of AI tools across design, customer experience, and marketing may compress Warby Parker's differentiation if competitors adopt similar capabilities, which could limit pricing power and keep adjusted gross margin anchored around current mid 50s levels rather than driving further structural expansion.
• Rising exposure to insurance based customers and pilots with large carriers may shift mix toward reimbursed purchases where payor policies and discount structures cap pricing flexibility, which could restrain average revenue per customer growth and hold back adjusted EBITDA margin progress.
• The move away from programs like Home Try on and Scout in favor of direct e commerce purchases and third party contacts reduces owned ecosystem touchpoints, and if AI driven tools and stores do not fully replace that engagement, active customer growth and repeat revenue cohorts could weaken, weighing on earnings over time.

Assumptions

This narrative explores a more pessimistic perspective on Warby Parker compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts. How have these above catalysts been quantified?

• The bearish analysts are assuming Warby Parker's revenue will grow by 13.6% annually over the next 3 years.
• The bearish analysts assume that profit margins will increase from 0.1% today to 21.5% in 3 years time.
• The bearish analysts expect earnings to reach $268.2 million (and earnings per share of $2.05) by about January 2029, up from $717.0 thousand today. The analysts are largely in agreement about this estimate.
• In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 10.8x on those 2029 earnings, down from 3854.1x today. This future PE is lower than the current PE for the US Specialty Retail industry at 19.8x.
• The bearish analysts expect the number of shares outstanding to grow by 1.08% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 8.52%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

• The eyewear and vision care market is described as large and resilient. Warby Parker reports nine consecutive quarters of accelerating active customer growth to 2.7 million customers with average revenue per customer of US$320, which suggests that sustained volume growth and stable customer cohorts could support revenue and earnings more than a bearish view assumes.
• Retail remains the primary growth engine with 313 stores and record retail productivity of 103.8%. New stores are performing in line with 35% four wall margins and 20 month paybacks. If this store fleet continues to scale with similar unit economics, operating leverage could support net margins and EBITDA.
• Contacts and eye exams are growing as a share of the mix, with contacts at 11.5% of revenue and eye exams at 6.5% of revenue and 41% year over year growth. If these higher engagement services keep scaling, they could lift average revenue per customer and support long term earnings quality.
• Management reports consistent revenue retention of roughly 50% over 24 months and over 100% over 48 months and highlights strong insurance cohorts and repeat purchasing. If this loyalty persists, it may underpin more stable revenue and gross profit than a sustained share price decline would imply.
• The company is already generating adjusted EBITDA of US$25.7 million in Q3 with an 11.6% margin and targets 2025 full year adjusted EBITDA of US$98 million to US$101 million and three consecutive years of positive free cash flow. Continued cost discipline and AI driven productivity gains could support margin expansion and free cash flow, challenging a thesis that assumes prolonged earnings pressure.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The assumed bearish price target for Warby Parker is $18.0, which represents up to two standard deviations below the consensus price target of $26.33. This valuation is based on what can be assumed as the expectations of Warby Parker's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
  
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $35.0, and the most bearish reporting a price target of just $18.0.
  
• In order for you to agree with the more bearish analyst cohort, you'd need to believe that by 2029, revenues will be $1.2 billion, earnings will come to $268.2 million, and it would be trading on a PE ratio of 10.8x, assuming you use a discount rate of 8.5%.
  
• Given the current share price of $22.62, the analyst price target of $18.0 is 25.7% lower. Despite analysts expecting the underlying business to improve, they seem to believe the market's expectations are too high.
  
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.